About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in California | 231 Studies

Clinical Trials Brain CancerCalifornia

Brain Cancer Clinical Trials in California

Find 231 clinical trials for brain cancer near California. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 231 trials

CompletedGimatecan in Treating Patients With Recurrent or Progressive Primary Malignant GliomaRATIONALE: Drugs used in chemotherapy, such as gimatecan, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00087061·Los Angeles, California CompletedClinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade GliomaThis is a 2 strata pilot trial within the Pacific Pediatric Neuro-Oncology Consortium (PNOC).NCT03739372·San Diego, California and 11 others CompletedAnti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)This phase I trial studies the safety and best dose of anti-LAG-3 (anti-LAG-3 monoclonal antibody BMS-986016) or urelumab alone and in combination with nivolumab in treating…NCT02658981·Birmingham, Alabama and 10 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedTesting Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain TumorsRecent advances in technology have allowed for the detection of cell-free DNA (cfDNA). cfDNA is tumor DNA that can be found in the fluid that surrounds the brain and spinal cord…NCT05934630·Los Angeles, California and 9 others

CompletedSU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation TherapyRATIONALE: SU5416 may stop the growth of astrocytoma or glioma by stopping blood flow to the tumor.NCT00004868·Los Angeles, California and 11 others

RecruitingThe RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)There are no guidelines or prospective studies defining the optimal surgical treatment for gliomas of older patients (≥70 years) or those with limited functioning performance at…NCT06146725·San Francisco, California and 7 others

CompletedMagnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for GliomasRATIONALE: Diagnostic procedures, such as magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI), (done before, during, and after treatment) may help…NCT00274755·San Francisco, California

CompletedMotexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade GliomasRATIONALE: New imaging procedures such as the use of gadolinium texaphyrin with MRI may improve the ability to detect the extent of gliomas.NCT00003410·Los Angeles, California

CompletedABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeRATIONALE: ABT-888 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Radiation therapy uses high-energy x-rays to kill tumor cells.NCT00770471·Birmingham, Alabama and 10 others

CompletedSafety Study of Afatinib for Brain CancerThe purpose of this study is to try to determine the maximum safe dose of afatinib that can be administered to people with brain cancer.NCT02423525·Santa Monica, California

CompletedSafety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma MultiformeThe purpose of this study is to determine the safety and efficacy of SL-701 as a treatment for recurrent glioblastoma multiform (GBM).NCT02078648·Birmingham, Alabama and 15 others

CompletedMagnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed GliomaRATIONALE: New imaging procedures such as magnetic resonance imaging may improve the ability to detect the extent of newly diagnosed cancer.NCT00005082·Los Angeles, California

RecruitingBeginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CareThis is a Phase 3 prospective, randomized, superiority, open-label, multi-site study. The overview of this study is as follows: * A Screening/Baseline Period of 21 days.NCT07195591·Scottsdale, Arizona and 21 others

CompletedBortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaRATIONALE: Bortezomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT00998010·Los Angeles, California

RecruitingTrial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent GlioblastomaThe purpose of this study is to assess the safety/tolerability/feasibility of pembrolizumab and radiation therapy before surgical resection in patients with recurrent glioblastoma…NCT04977375·Los Angeles, California

CompletedBevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or GliosarcomaThis randomized phase II trial is studying the side effects and how well giving bevacizumab together with irinotecan or temozolomide works in treating patients with recurrent or…NCT00433381·Mobile, Alabama and 92 others

CompletedPPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT MethylationTo obtain preliminary data in a randomized phase II study whether PPX/RT improves progression-free survival as compared to temozolomide/RT for patients with GBM without MGMT…NCT01402063·La Jolla, California and 8 others

TerminatedDasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsRATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00788125·Duarte, California

CompletedStage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and BevacizumabThis is a Phase 1/2 clinical trial to evaluate a new combination of drugs, marizomib (MRZ) and bevacizumab (BEV; Avastin®), for the treatment of WHO Grade IV malignant glioma.NCT02330562·Orange, California and 4 others

CompletedTemozolomide in Treating Patients With Recurrent High-Grade GliomaRATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT00619112·San Francisco, California

PreviousPage 4 of 12Next

Other Conditions in California

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia